挪威的牛皮:对牛皮相关的并发病的基于处方的注册研究
1Department of Dermatology, Haukeland University Hospital, Bergen, Norway, Department of Clinical Medicine, University of Bergen, Bergen, Norway.
European journal of dermatology : EJD
|March 11, 2024
概括
皮肤牛皮患者经常有其他健康问题,常见的处方是心血管疾病和抑郁症. 这些现实数据突出显示了牛皮患者的大量并发症负担.
科学领域:
- 皮肤病学 皮肤病学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 牛皮是一种炎症性皮肤疾病,通常与其他健康问题 (并发症) 相关.
- 了解这些并发症对于全面的患者护理至关重要.
研究的目的:
- 识别和描述与皮肤牛皮相关的并发症.
- 分析皮病患者的现实处方数据.
主要方法:
- 从2004年到2020年使用了挪威处方数据库 (NorPD).
- 包括患有牛皮的患者,以及对某些并发症的诊断代码和处方.
- 分析了用于动脉样硬化疾病初级预防的处方数据,确定了动脉样硬化疾病,抑郁症和其他疾病.
主要成果:
- 对牛皮患者最常见的处方是动脉样硬化疾病预防 (22.6%),已确定的动脉样硬化疾病 (19.3%) 和抑郁症 (18.4%).
- 其他常见的并发症包括心力衰竭 (16.1%),II型糖尿病 (9.4%) 和高血压 (9.4%).
- 与普通人群相比,牛皮患者的各种疾病处方率较高.
结论:
- 皮肤牛皮与大量的并发症有关,特别是心血管疾病和精神健康状况.
- 现实世界的数据证实了对牛皮及其相关健康问题的综合管理的需要.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
137
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
137
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
118
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
118
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163
COPD: Pathogenesis and Clinical Features
272
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
272
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
206
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206


